14-day Premium Trial Subscription Try For FreeTry Free
NASDAQ:TYME
Delisted

Tyme Technologies Inc Stock Predictions

NASDAQ Stock Exchange > Healthcare > Biotechnology
Open Broker Account
$0.311
+0 (+0%)
At Close: Jan 27, 2023
Forecast Insider Trading Signals Historical Prices Predictions News Profile
Currently predicting for Wed, 8 May 2024

TYME Predictions History

3 years ago
 JS predicted that TYME for 2021-02-05 is going $2.70 (13.45%)

3 years ago
 Jackie B predicted that TYME for 2021-02-05 is going $2.26 (-5.04%)

Rank:

3 years ago
 Grant Lang predicted that TYME for 2021-02-05 is going

Rank:

3 years ago
 JS predicted that TYME for 2020-12-02 is going $1.06 (-5.36%)

5 years ago
 NameNotImportant predicted that TYME for 2019-05-06 is going $1.50 (-5.66%)

5 years ago
 NameNotImportant predicted that TYME for 2019-04-29 is going $1.41 (-3.42%)

Click to get the best stock tips daily for free!

About Tyme Technologies Inc

Tyme Technologies Tyme Technologies, Inc., a biotechnology company, develops cancer metabolism-based therapies (CMBTs) in the United States. Its lead drug product is SM-88, a CMBT that is in a Phase II/III clinical trial to treat across 15 types of cancer, including pancreatic, prostate, breast, lung, glioma, ovarian, sarcoma, and colon. The company is also developing TYME-19, an oral synthetic member of the bile acid family, which is in preclinical stage for the ... TYME Profile

Golden Star

Ticker Date Change Price
TMO May 02 0.403% $571.25
STNG May 02 0.699% $71.50
DLR May 02 2.58% $140.15
RF May 02 0.97% $19.64
INVH May 02 0.87% $34.50
SMAR May 02 2.24% $38.39
BIRK May 02 0.650% $44.61
FTSL May 02 0.217% $46.11
VCSH May 02 0.287% $76.71
VRNT May 02 2.44% $30.78
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT